gastric emptying glp-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) have become incredibly common in diabetes and weight-management care, and they're now showing up more and more in the perioperative setting. These GLP-1 Gut Side Effects: Bloating

USADA BPC-157 is een experimenteel peptide en verboden voor atleten in competitieverband

The proposed mode of action of AOD 9604 has been suggested by researchers to be restricted to promoting lipolysis, thus linking the synthetic compound to obesity research

Rapid injection is one of the primary causes of nodule formation and post-injection discomfort

Effect of alcohol abuse and glutathione administration on the circulating levels of glutathione and on antipyrine metabolism in patients with alcoholic liver cirrhosis

Wegovy (semaglutide) is a GLP-1 receptor agonist that reduces appetite, slows gastric emptying, and supports weight management when combined with lifestyle changes

Figure 2: Pathogenesis of type 1 and type 2 diabetes